Trelleborg launches BioPharmaPro product line
HomeHome > Blog > Trelleborg launches BioPharmaPro product line

Trelleborg launches BioPharmaPro product line

Feb 12, 2024

August 11, 2023 By MDO Staff

Trelleborg Healthcare & Medical’s BioPharmaPro range supports customers with products including fully assembled chromatography equipment with advanced composite columns. [Image courtesy of Trelleborg]

Building on its history of innovation, Trelleborg Healthcare & Medical’s BioPharmaPro range delivers solutions created from a vast portfolio of materials, including silicones, other elastomers, thermoplastics, and composites, which can be manufactured into tubing, custom molded components, processing columns, up to full assemblies, and much more.

Solutions range from individual single-use components to complex assemblies and full biopharmaceutical systems manufactured from a wide portfolio of polymer materials meeting functionality, cleaning and sterilization, and regulatory requirements. State-of-the-art equipment, processes and advanced manufacturing technology produce innovative and reliable precision components and assemblies created using extrusion, molding, composites and various other technologies.

Systems can be produced in ISO 7 and ISO 8 cleanrooms and all components meet cleanliness and biocompatibility requirements, including BioPhorum Operations Groups (BPOG) Extractables & Leachables standards for silicone tubing. Integrated solutions, including full assemblies, packaging and kitting enable supplier consolidation.

Florance Veronelli, Segment Manager Healthcare & Medical Europe, says: ”Because single-use systems perform critical functions, we build strong partnerships with our customers to collaboratively develop innovative solutions to optimize outcomes. When customers approach us with their ideas for innovative components and devices, we work with them at every step to turn these ideas into reality.

”BioPharmaPro’s combination of polymer materials expertise, advanced manufacturing processes, innovative engineering and quality assurance enables us to provide unsurpassed support to accelerate the business of our biopharmaceutical customers.”

Trelleborg Healthcare & Medical supports biopharmaceutical companies with a full range of products, from single-use tubing and tubing sets and custom molded parts to full assemblies for filtration or chromatography equipment with advanced composite columns.

Mike Urbanski, Business Development Manager BioPharma, adds: ”In the post-Covid world, biopharmaceutical development is increasingly rapid and development times need to be short. But the market structure is also changing rapidly. System suppliers are shifting their focus away from product engineering to process engineering and drug development. Therefore reliable contract manufacturers and long-term partnerships are needed, as they can support with their capacity in development and manufacturing of mechanical systems.

”Trelleborg’s BioPharmaPro adds value for customers through our one-stop shop for complete integrated solutions, from simple products to complex assemblies, allowing system suppliers to focus on drug development while outsourcing the product engineering and consolidating their supply chain.”

The wide BioPharmaPro range includes platinum-cured silicone tubing; braided hose which are reinforced for higher pressure applications; fittings for tubing and connectors; and vulcanized and non-vulcanized sheeting. It also features liquid silicone rubber (LSR) parts available in complex geometries; multi-component parts in one bonded solution; advanced composite materials; and engineered-grade molded thermoplastic parts. Further services for all components ensure appropriate cleanliness, fully traceable marking and labeling and – with final assembly – to full solutions for biopharmaceutical system suppliers.

Click here for more information, including access to the on-demand BioPharmaPro webinar.

The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.

The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.